BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10817846)

  • 41. [Longevity promoting beta blocker. Soon in 1st place in heart failure?].
    MMW Fortschr Med; 2003 Sep; 145(37):60. PubMed ID: 14584447
    [No Abstract]   [Full Text] [Related]  

  • 42. Heart failure in 10 years time: focus on pharmacological treatment.
    McMurray JJ
    Heart; 2002 Oct; 88 Suppl 2(Suppl 2):ii40-6. PubMed ID: 12213800
    [No Abstract]   [Full Text] [Related]  

  • 43. Pharmacological treatment of chronic heart failure.
    Adorisio R; De Luca L; Rossi J; Gheorghiade M
    Heart Fail Rev; 2006 Jun; 11(2):109-23. PubMed ID: 16937030
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Matters of the heart. Life-saving drugs for cardiac disease are still underused.
    Paul KJ
    Contemp Longterm Care; 1999 Jun; 22(6):53. PubMed ID: 10538230
    [No Abstract]   [Full Text] [Related]  

  • 45. Novel targets for the treatment of heart failure: perspectives from a heart failure clinician and trialist.
    Massie BM
    J Mol Cell Cardiol; 2011 Oct; 51(4):438-40. PubMed ID: 21549124
    [No Abstract]   [Full Text] [Related]  

  • 46. Prognosis determination in heart failure.
    Eichhorn EJ
    Am J Med; 2001 May; 110 Suppl 7A():14S-36S. PubMed ID: 11334772
    [No Abstract]   [Full Text] [Related]  

  • 47. [Adrenergic activation in heart failure: blockade or rebalance?].
    Emdin M; Vergaro G; Giannoni A; Passino C
    G Ital Cardiol (Rome); 2010 Mar; 11(3):229-32. PubMed ID: 20550063
    [No Abstract]   [Full Text] [Related]  

  • 48. Angiotensin receptor blockers for chronic heart failure and acute myocardial infarction.
    McMurray JJ
    Heart; 2001 Jul; 86(1):97-103. PubMed ID: 11410575
    [No Abstract]   [Full Text] [Related]  

  • 49. beta-blockers, angiotensin II, and ACE inhibitors in patients with heart failure.
    Campbell DJ; Aggarwal A; Esler M; Kaye D
    Lancet; 2001 Nov; 358(9293):1609-10. PubMed ID: 11716889
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Aldosterone blocker in heart failure: life prolonging even in mild symptoms].
    MMW Fortschr Med; 2010 Dec; 152(48):12-3. PubMed ID: 21226226
    [No Abstract]   [Full Text] [Related]  

  • 51. Beta-blockers in chronic heart failure.
    Gheorghiade M; Colucci WS; Swedberg K
    Circulation; 2003 Apr; 107(12):1570-5. PubMed ID: 12668487
    [No Abstract]   [Full Text] [Related]  

  • 52. [Clinical significance of RAS block in heart diseases].
    Saito Y
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1750-5. PubMed ID: 17037310
    [No Abstract]   [Full Text] [Related]  

  • 53. [Is it always necessary to use triple combination in the treatment of patients with chronic cardiac failure? Choice of the third neurohormonal blocker].
    Belenkov IuN; Mareev VIu; Skvortsov AA
    Ter Arkh; 2008; 80(9):5-12. PubMed ID: 19555028
    [No Abstract]   [Full Text] [Related]  

  • 54. ACE inhibitors and beta blockers in chronic congestive cardiac failure: therapeutic basis.
    Manoria PC; Manoria P
    J Indian Med Assoc; 2003 May; 101(5):311-2, 315. PubMed ID: 14575221
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Contemporary management of heart failure in clinical practice.
    Cleland JG
    Heart; 2002 Oct; 88 Suppl 2(Suppl 2):ii5-8. PubMed ID: 12213792
    [No Abstract]   [Full Text] [Related]  

  • 56. [Management of hypertensive patients with cardiovascular damage].
    Tomiyama H; Takata Y; Yamashina A
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():612-6. PubMed ID: 15171444
    [No Abstract]   [Full Text] [Related]  

  • 57. Managing patients with heart failure: the reality of clinical practice.
    Squire I
    Eur Heart J; 2005 Dec; 26(24):2611-3. PubMed ID: 16219652
    [No Abstract]   [Full Text] [Related]  

  • 58. Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center.
    Bress AP; King JB; Brixner D; Kielhorn A; Patel HK; Maya J; Lee VC; Biskupiak J; Munger M
    Pharmacotherapy; 2016 Feb; 36(2):174-86. PubMed ID: 26841333
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Survival of rats with experimental chronic heart failure depending on pharmacodynamic and pharmacokinetic parameters of angiotensin-converting enzyme inhibitors and beta-adrenoceptor blockers.
    Fedorov VN; Sal'nikov EV; Sidorov AV; Bogatushin AV; Fateev MM
    Bull Exp Biol Med; 2006 Jan; 141(1):40-3. PubMed ID: 16929960
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The European Society of Cardiology (ESC) Annual Meeting 2005.
    von Haehling S
    Heart Fail Monit; 2005; 4(4):150-2. PubMed ID: 16234901
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.